GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better orthopedic outcomes in semaglutide users.
  |
| 💉 A guide to GLP-1s. Abdomen, thigh, or upper arm — where you inject your GLP-1 matters more than you'd think. Learn the best injection sites and why rotating them is key. | | | | | |
We'd love to hear from you in the meantime, so please send any feedback, comments, suggestions, or questions to the team by email. Reminder: Add newsletter@medicalnewstoday.com to your contact list so you don't miss a single update. Kindly, The Medical News Today team | | | | |
| |  | | | | | | | You are receiving this newsletter because you subscribed on our web site, Medical News Today. | | Did a friend send you this email? Subscribe here. | | View in Browser | Privacy Policy | Unsubscribe | Our website services, content, and products are for informational purposes only. Medical News Today does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Medical News Today encourages you to make any treatment decisions with your healthcare professional. Medical News Today is owned by RVO Health. © 2026 RVO Health 1101 Red Ventures Drive Fort Mill, SC 29707 | | | | | | |
Comments
Post a Comment